UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
Form 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 25, 2009
Streamline Health Solutions, Inc.
(Exact name of registrant as specified in its charter)
| |
|
|
|
|
| Delaware
|
|
0-28132
|
|
31-1455414 |
|
|
|
|
|
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.) |
| |
|
|
| 10200 Alliance Road, Suite 200, Cincinnati, OH
|
|
45242-4716 |
|
|
|
|
| (Address of principal executive offices)
|
|
(Zip Code) |
Registrant’s telephone number, including area code (513) 794-7100
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing
obligation of the registrant under any of the following provisions:
| o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
| o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
| o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b)) |
| |
| o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c)) |
TABLE OF CONTENTS
Item 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN
OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS
On February 25, 20098, the Board of Directors of Streamline Health Solutions, Inc. expanded
the size of the Board to six members and appointed Jay D. Miller to fill the vacancy created by
such expansion.
Mr. Miller has approximately 25 years of experience in the medical technology industry. Since
January 2008, Mr. Miller has been consulting for a number of companies. From February 2002 until
January 2008, Mr. Miller was President, Chief Executive Officer and a director of Vital Images,
Inc., a publicly traded company that provides enterprise-wide advanced visualization and analysis
software solutions. He served as General Manager and Vice President-Business Development of Vital
Images from August 1998 until February 2002, and as Vice President-Marketing and Business
Development for Vital Images from February 1997 to August 1998. From 1989 until his employment by
Vital Images, Mr. Miller was employed by GE Medical Systems, Inc. in various marketing positions of
increasing responsibility in the marketing area, including serving as product manager of MRI
imaging products and marketing manager for the cardiology market segment. Before 1989, Mr. Miller
was employed by Siemens Medical Systems in technical marketing.
There are no arrangements or understandings between Mr. Miller and Streamline Health or any
other persons pursuant to which Mr. Miller was selected as a director of Streamline Health.
Consistent with board policy, Mr. Miller should receive 15,000 nonqualified stock options for
his appointment to the Board. It is expected that these options will be granted at the next
regularly scheduled board meeting.
There are no family relationships between Mr. Miller and any Director or Executive Officer of
Streamline Health. Since the beginning of Streamline Health’s last fiscal year, Mr. Miller has had
no relationships with Streamline Health that would require disclosure under Item 404 of Regulation
S-K.
Item 7.01 REGULATION FD DISCLOSURE
On February 26, 2009, Streamline Health issued a press release announcing the appointment of
Mr. Miller to its Board of Directors as described above. A copy of the press release is attached
as Exhibit 99.1 to this report and is incorporated by reference into this Item 7.01. The
information in this Item 7.01, including the press release, is being furnished and shall not be
deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended,
or otherwise subject to the liabilities of that Section.
2